TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
RNXT

RenovoRx Inc

Healthcare · Biotechnology

1.60$ -6.6% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

RenovoRx Inc (RNXT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -11 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow RNXT
Line item 2019 2020 2021 2022 2023 2024 2025
-3.4 -3.5 -5.9 -8.8 -10 -9.1 -11
0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.0 0.1 0.1 0.6 1.1 1.2 1.3
0.0 0.1 0.0 – – – –
0.4 -0.3 -0.3 0.4 0.6 0.3 -0.2
0.0 0.0 0.0 0.0 0.0 0.0 0.0
0.0 0.0 0.0 -2.0 2.0 0.0 0.0
3.2 3.2 2.0 0.0 – – –
3.2 3.2 19 0.0 5.0 15 11
-3.4 -0.3 13 -11 -3.2 6.0 -0.1
-3.4 -3.5 -5.9 -8.8 -10 -9.1 -11

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?